Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DYRK1A | Q13627 | 2/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 6/20 | 0.36 |
| ▸ | CYP1A1 | P04798 | 5/20 | 0.36 |
| ▸ | CYP1B1 | Q16678 | 5/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | PIM1 | P11309 | 2/20 | 0.35 |
| ▸ | CSNK2A1 | P68400 | 2/20 | 0.35 |
| ▸ | CSNK2A2 | P19784 | 1/20 | 0.35 |
| ▸ | CSNK2B | P67870 | 1/20 | 0.35 |
| ▸ | CSNK2A3 | Q8NEV1 | 1/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.34 |
| ▸ | HPGD | P15428 | 2/20 | 0.34 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.34 |
| ▸ | THRB | P10828 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.33 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.33 |
| ▸ | HTR2C | P28335 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12278571 | 0.92 | PIM1 (0.42) | DYRK1ACYP1A2CYP1A1CYP1B1KMT2A | |
| SCHEMBL12277889 | 0.88 | CYP3A4 (0.44) | DYRK1ACYP1A1KMT2ACYP3A4MAPK1 | |
| SCHEMBL18177588 | 0.87 | PIM1 (0.44) | DYRK1ACYP1A2CYP1A1CYP1B1KMT2A | |
| SCHEMBL12277944 | 0.85 | EPHX2 (0.38) | DYRK1ACYP1A2CYP1A1CYP1B1HPGD | |
| SCHEMBL9961317 | 0.82 | DYRK1A (0.47) | DYRK1ACYP1A2CYP1A1CYP1B1KMT2A | |
| SCHEMBL12277878 | 0.81 | CYP3A4 (0.47) | DYRK1ACYP1A1PIM1CSNK2A1CSNK2A2 | |
| SCHEMBL19222465 | 0.79 | MAOB (0.55) | CYP1A2CYP1A1CYP1B1CYP3A4HPGD | |
| SCHEMBL12277888 | 0.78 | EPHX2 (0.38) | DYRK1ACYP1A2CYP1A1CYP1B1PIM1 | |
| SCHEMBL19486063 | 0.77 | DYRK1A (0.44) | DYRK1ACYP1A2CYP1A1PIM1CSNK2A1 | |
| SCHEMBL25165205 | 0.77 | DYRK1A (0.44) | DYRK1ACYP1A2CYP1A1CYP1B1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8785915-B2 | Compound for organic thin film transistor and organic thin film transistor using the same | IDEMITSU KOSAN CO., LTD. (JP) | 2014-07-22 | — | — | US | disclosed |
| US-8785915-B2 | Compound for organic thin film transistor and organic thin film transistor using the same | IDEMITSU KOSAN CO., LTD. (JP) | 2014-07-22 | — | — | US | disclosed |
| US-20110210319-A1 | COMPOUND FOR ORGANIC THIN FILM TRANSISTOR AND ORGANIC THIN FILM TRANSISTOR USING THE SAME | COMPOUND FOR ORGANIC THIN FLIM TRANSISTOR AND ORGANIC THAN FLIM TRANSITOR USING THE SAME (JP) | 2011-09-01 | — | — | US | disclosed |
| US-20110210319-A1 | COMPOUND FOR ORGANIC THIN FILM TRANSISTOR AND ORGANIC THIN FILM TRANSISTOR USING THE SAME | COMPOUND FOR ORGANIC THIN FLIM TRANSISTOR AND ORGANIC THAN FLIM TRANSITOR USING THE SAME (JP) | 2011-09-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110210319-A1 | COMPOUND FOR ORGANIC THIN FILM TRANSISTOR AND ORGANIC THIN FILM TRANSISTOR USING THE SAME | OR10J3, TCF4, CTCF | DYRK1A 3645/4885CYP1A2 386/4885CYP1A1 87/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.